Page 4 - Pharma Analyst News Today

After successfully completing Phase III trials of oral insulin, Chinas Hefei Tianhui Biotechnology (HTIT) submitted a marketing authorisation application (MAA) to the countrys National Medical Products Administration.Oram

A $5.9 billion acquisition of biotech Iveric Bio by Astellas is set to accelerate development of treatments for blinding retinal diseases.

New Delhi, April 10: The recent update on Covid-19 vaccine and booster dose by the World Health Organization (WHO) can lead to reduction in global demand and revenue for vaccines against the deadly infectious disease, according to a report on Monday.

The recent update on Covid-19 vaccine and booster dose by the World Health Organization (WHO) can lead to reduction in global demand and revenue for vaccines against the deadly infectious disease, according to a report on Monday.The WHO ...

05 Apr, 2023 Alzheimers drug Leqembi will generate $12.9 billion in sales by 2028, forecasts GlobalData Share Print page ... | April 5, 2023

24 Mar, 2023 Dr. Reddys focuses on differentiated portfolio in key therapy areas as part of India growth strategy, says GlobalData Share ... | March 24, 2023

Despite their benefits, new therapies for respiratory syncytial virus (RSV) may accelerate the emergence of drug-resistant strains, according to a new report on Monday.Given the large market potential and high unmet need for new RSV therapies, ...

New York, March 13 (IANS) Despite their benefits, new therapies for respiratory syncytial virus (RSV) may accelerate the emergence of drug-resistant strains,

The recently approved Pune-based Gennova Biopharmaceuticals' two-dose mRNA Covid-19 vaccine, expected to be soon available in the country, is likely to see low penetration in the Indian market, according to a report on Monday.The jab ...

The affordable vaccine will significantly improve the overall penetration and help address the growing number of cervical cancer